Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. - Wikidata - wikimedia - TriplyDB

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

http://www.wikidata.org/entity/Q33148761

about

Clinical Applications of Natriuretic Peptides in Assessment of Valvular Heart Disease Morbid obesity: obscuring the diagnosis of aortic stenosis in a patient with cardiogenic wheezing Care of patients with apparently asymptomatic severe aortic valve stenosis Plasma brain natriuretic peptide concentrations in patients with valvular heart disease EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Left ventricular reverse remodeling after transcatheter aortic valve implantation: a cardiovascular magnetic resonance study.B-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic study Aortic stiffness as a marker of cardiac function and myocardial strain in patients undergoing aortic valve replacement Can Brain Natriuretic Peptides and Osteoprotegerin Serve As Biochemical Markers for the Detection of Aortic Pathology in Children and Adolescents with Turner Syndrome?Insights into the use of biomarkers in calcific aortic valve disease The role of B-type and other natriuretic peptides in health and disease.Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanisms and future prognostic implications.Correlation between B-Type Natriuretic Peptide and Functional/Cognitive Parameters in Discharged Congestive Heart Failure Patients.Acquired aortic stenosis.Prognostic value of N-terminal pro-B-type natriuretic peptide for conservatively and surgically treated patients with aortic valve stenosis Depressed Systemic Arterial Compliance is Associated with the Severity of Heart Failure Symptoms in Moderate-to-Severe Aortic Stenosis: a Cross-Sectional Retrospective Study.Longitudinal left ventricular contractile dysfunction after exercise in aortic stenosis.Brain natriuretic peptide in the contemporary management of congestive heart failure.Clinical and laboratory diagnostics of cardiovascular disease: focus on natriuretic peptides and cardiac ischemia.B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.Natriuretic peptides in heart valve disease.The prognostic value of N-terminal proB-type natriuretic peptide.Aortic stenosis at young adult age.Natriuretic peptides in acute and chronic kidney disease and during renal replacement therapy.Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine N-terminal pro-B-type natriuretic peptide measurement is useful in predicting left ventricular hypertrophy regression after aortic valve replacement in patients with severe aortic stenosis.Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload Physiology and clinical significance of natriuretic hormones Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Strain in Patients With Significant Aortic Stenosis.Usefulness of the brain natriuretic peptide to atrial natriuretic peptide ratio in determining the severity of mitral regurgitation.Optimum management of elderly patients with calcified aortic stenosis.New cardiovascular biomarkers: clinical implications in patients with valvular heart disease.Usefulness of serial brain natriuretic peptide measurements for managing aortic valve stenosis in pregnancy.The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology.Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.B-type natriuretic peptides in heart failure: update on clinical applications and limitations.Updating the role of natriuretic peptide levels in cardiovascular disease.Review on natriuretic peptides: where we are, where we are going.Markers of left ventricular decompensation in aortic stenosis.

P2860

Q26799058-224D57E3-B616-4FC3-BA4A-FE732BE4EBEC Q27005608-72FBD064-EA01-4625-91BD-3BD576024C30 Q27027825-86652C48-AC44-4FD6-BFE3-F7DF382BD506 Q28603050-5DF87983-5389-4086-A97B-3A2788A84E31 Q30375302-6E2CCA05-EB22-4D92-922F-E6A27647C4EC Q30453765-BA5122B0-1EA0-4DAF-A4C4-0223F199EDD5 Q33387034-74C6BE96-6415-4A14-9A3E-4A1EF0E36C9A Q33824641-B7937D0D-8005-48A2-8B71-DF988E08B931 Q33867461-3BC930A9-89F8-4A1A-8F4F-F19446FBDD3F Q34139677-EC54ABF1-F782-489D-9F73-28B3BDFCA105 Q34566491-D1891797-AF2A-4485-9A06-7FD2973FE158 Q35535837-C1CEF3B6-6BDC-4D2C-A044-FE4B43ADBC86 Q35573378-EFA4025E-714D-423D-BB93-329F34C42B52 Q35706904-DD0EAEC3-9261-4F46-879C-9D5924913874 Q35772550-24FDEAD5-5E16-44B9-ABFB-90B1198AAECF Q35850978-B63D0966-3E85-42B0-BA7C-64412AADE6F4 Q35954691-1876A6AA-B712-429F-BD71-8C2953F82836 Q36050481-CA8FDAEB-E136-4E23-83B0-4A6FF0AA26AC Q36236490-BA0AB526-894E-4967-B2C7-466E75B334B2 Q36245755-1AD3E2F8-4A0F-4071-8521-ADC3C783AAE9 Q36297946-F4D20E80-1817-4D87-A2E3-DDAD48A2A2E5 Q36304293-31E8967F-373E-47AA-887A-74C6F04B787A Q36314868-103B706E-6251-4B4F-92D5-1FC87C88A16C Q36317204-2D7918E2-DF4A-4C76-B579-81D3A8D70E42 Q36477929-2B834DB1-F7F9-4EB7-875F-E1A49A9D57D2 Q36801073-A7BD3732-C310-443A-A3C9-A9582148580B Q36825438-EA231FBE-9247-4B6D-A2BE-721002D87540 Q36830845-79D3D9FA-EF7C-4DFA-B03A-4EE9BAFBB9BD Q36862282-E0FF4954-0E01-4FB6-980D-2ADD33F1E658 Q36877646-BDA3EE0E-FF74-42AE-9D3B-AF2A17E6B591 Q37109943-9C1F0F94-CBC1-4911-A719-C65B92F41631 Q37134478-518CF726-D67A-4453-9B83-B8298F801408 Q37230379-CEB087DB-B8EB-4F73-B55C-D05A0496CD1B Q37257886-3742BC37-366C-4D40-93C8-89BE3ABDDE74 Q37277937-41BD7570-3879-47A3-8899-4417FFBE8A1F Q37593775-BF29FA47-D66F-4CCB-B5DD-98CC9BB0621B Q37755062-D416FED1-AC07-4F3B-8821-02E49EC6EEC4 Q37959158-EFF54212-E0DB-435F-B60C-BC4EA7016C6D Q38089931-7E021C0C-A0D9-49BF-A34E-C20487EE1192 Q38215381-80A5ABB7-3FC7-4C15-B1F5-599FF0D53368

P2860

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

http://www.wikidata.org/entity/Q33148761

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@ast

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@en

type

label

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@ast

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@en

prefLabel

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@ast

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@en

P1433

Q33148761-3F6BC136-D8E8-4E63-A4CC-5A934197A4F9

P1476

Q33148761-1A4F74B5-D13E-49FA-BADD-AD18F5B8D325

P2093

Q33148761-34CF728B-89A3-4BB1-87E4-08AFCAD1BE1B

Q33148761-36133BE5-1CD6-4BE3-A6F0-1CB30BD90E6F

Q33148761-544A4D46-E152-46EF-9181-82598CD0384B

Q33148761-572337A5-670D-4316-9A36-917E17C58219

Q33148761-5DFE0E92-E44C-4B8D-8D1C-1823C72B6A83

Q33148761-7D26E3C5-99F5-4CB9-81ED-D564EB5796FF

Q33148761-8FB01512-F3FB-4EA1-9070-1C448CD21992

Q33148761-98819213-14F6-49BB-A2F5-DC7E0C44CCAA

Q33148761-C0659CBB-DB1B-4C60-B9CE-ED660CA2A56D

Q33148761-CFC32C80-A0C2-49C1-9966-46B48CAC7D1B

P304

Q33148761-782476A3-031F-453E-9213-9DD51A9E6E54

P31

Q33148761-2D782F10-5A22-407C-9FCA-5AF0DA6F7B1B

P356

Q33148761-286E412A-DD4B-4EBC-8A23-7D1F6315E5C7

P407

Q33148761-2B744583-D9A4-4CD9-9B45-69A1FBBD664A

P433

Q33148761-ED4F780E-56A4-4F0C-AEE5-7BABB8910689

P478

Q33148761-1A5B1402-2827-4B6A-AAC5-6A99CA235112

P577

Q33148761-3632B6F2-0314-4B33-A730-3320ABC11709

P5875

Q33148761-ED697AAD-2294-42EE-A68C-4E21668A907B

P698

Q33148761-39860C09-3236-44EB-A547-CB02B79E25FC

P921

Q33148761-05155606-85DF-4C03-8FC2-DA05558D587F

P356

01.CIR.0000060533.79248.0C

P1433

P1476

Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.

@en

P2093

A Mark Richards

http://www.w3.org/2001/XMLSchema#string

Harvey D White

http://www.w3.org/2001/XMLSchema#string

Ivor L Gerber

http://www.w3.org/2001/XMLSchema#string

John K French

http://www.w3.org/2001/XMLSchema#string

Malcolm E Legget

http://www.w3.org/2001/XMLSchema#string

Ralph A H Stewart

http://www.w3.org/2001/XMLSchema#string

Renelle L French

http://www.w3.org/2001/XMLSchema#string

Teena M West

http://www.w3.org/2001/XMLSchema#string

Timothy G Yandle

http://www.w3.org/2001/XMLSchema#string

Timothy M Sutton

http://www.w3.org/2001/XMLSchema#string

P304

1884-1890

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1161/01.CIR.0000060533.79248.0C

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10827462

http://www.w3.org/2001/XMLSchema#string

P698

12668523

http://www.w3.org/2001/XMLSchema#string

P921